Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.
Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(9):960-968. doi: 10.1093/abbs/gmz075.
Nα-acetylation is a universal protein modification related to a wide range of physiological processes in eukaryotes and prokaryotes. RimI, an Nα-acetyltransferase in Mycobacterium tuberculosis, is responsible for the acetylation of the α-amino group of the N-terminal residue in the ribosomal protein S18. Despite growing evidence that protein acetylation may be correlated with the pathogenesis of tuberculosis, no structural information is yet available for mechanistically understanding the MtRimI acetylation. To enable structural studies for MtRimI, we constructed a serial of recombinant MtRimI proteins and assessed their biochemical properties. We then chose an optimal construct MtRimIC21A4-153 and expressed and purified the truncated high-quality protein for further biophysical and functional characterizations. The 2D 1H-15N heteronuclear single quantum coherence spectrum of MtRimIC21A4-153 exhibits wider chemical shift dispersion and favorable peak isolation, indicating that MtRimIC21A4-153 is amendable for further structural determination. Moreover, bio-layer interferometry experiments showed that MtRimIC21A4-153 possessed similar micromolar affinity to full-length MtRimI for binding the hexapeptide substrate Ala-Arg-Tyr-Phe-Arg-Arg. Enzyme kinetic assays also exhibited that MtRimIC21A4-153 had almost identical enzymatic activity to MtRimI, indicating insignificant influence of the recombinant variations on enzymatic functions. Furthermore, binding sites of the peptide were predicted by molecular docking approach, suggesting that this substrate binds to MtRimI primarily through electrostatic and hydrogen bonding interactions. Our results lay a foundation for the further structural determination and dynamics detection of MtRimI.
Nα-乙酰化是一种普遍存在的蛋白质修饰,与真核生物和原核生物中广泛的生理过程有关。结核分枝杆菌 RimI 是一种 Nα-乙酰转移酶,负责核糖体蛋白 S18 的 N 端残基的α-氨基基团的乙酰化。尽管越来越多的证据表明蛋白质乙酰化可能与结核病的发病机制有关,但目前尚无关于 MtRimI 乙酰化的机制理解的结构信息。为了能够对 MtRimI 进行结构研究,我们构建了一系列重组 MtRimI 蛋白,并评估了它们的生化特性。然后,我们选择了一个最佳的构建体 MtRimIC21A4-153,并表达和纯化了截断的高质量蛋白,用于进一步的生物物理和功能表征。MtRimIC21A4-153 的二维 1H-15N 异核单量子相干谱显示出更宽的化学位移分散和良好的峰分离,表明 MtRimIC21A4-153 适合进一步的结构测定。此外,生物层干涉测量实验表明,MtRimIC21A4-153 与全长 MtRimI 对结合六肽底物 Ala-Arg-Tyr-Phe-Arg-Arg 的亲和力相似,均为微摩尔级。酶动力学测定也表明,MtRimIC21A4-153 与 MtRimI 具有几乎相同的酶活性,表明重组变异对酶功能的影响不大。此外,通过分子对接方法预测了肽的结合位点,表明该底物主要通过静电和氢键相互作用与 MtRimI 结合。我们的结果为进一步的 MtRimI 结构测定和动力学检测奠定了基础。